000120649 001__ 120649
000120649 005__ 20240228145458.0
000120649 0247_ $$2doi$$a10.1002/ijc.30697
000120649 0247_ $$2pmid$$apmid:28316084
000120649 0247_ $$2ISSN$$a0020-7136
000120649 0247_ $$2ISSN$$a1097-0215
000120649 037__ $$aDKFZ-2017-01076
000120649 041__ $$aeng
000120649 082__ $$a610
000120649 1001_ $$00000-0002-5010-5236$$aHolzinger, Dana$$b0$$eFirst author
000120649 245__ $$aSensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
000120649 260__ $$aBognor Regis$$bWiley-Liss$$c2017
000120649 3367_ $$2DRIVER$$aarticle
000120649 3367_ $$2DataCite$$aOutput Types/Journal article
000120649 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1660741997_9237
000120649 3367_ $$2BibTeX$$aARTICLE
000120649 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000120649 3367_ $$00$$2EndNote$$aJournal Article
000120649 520__ $$aTo determine the sensitivity and specificity of HPV16 serology as diagnostic marker for HPV16-driven oropharyngeal squamous cell carcinoma (OPSCC), 214 HNSCC patients from Germany and Italy with fresh-frozen tumor tissues and sera collected before treatment were included in this study. Hundred and twenty cancer cases were from the oropharynx and 94 were from head and neck cancer regions outside the oropharynx (45 oral cavity, 12 hypopharynx and 35 larynx). Serum antibodies to early (E1, E2, E6 and E7) and late (L1) HPV16 proteins were analyzed by multiplex serology and were compared to tumor HPV RNA status as the gold standard. A tumor was defined as HPV-driven in the presence of HPV16 DNA and HPV16 transformation-specific RNA transcript patterns (E6*I, E1(∧) E4 and E1C). Of 120 OPSCC, 66 (55%) were HPV16-driven. HPV16 E6 seropositivity was the best predictor of HPV16-driven OPSCC (diagnostic accuracy 97% [95%CI 92-99%], Cohen's kappa 0.93 [95%CI 0.8-1.0]). Of the 66 HPV-driven OPSCC, 63 were HPV16 E6 seropositive, compared to only one (1.8%) among the 54 non-HPV-driven OPSCC, resulting in a sensitivity of 96% (95%CI 88-98) and a specificity of 98% (95%CI 90-100). Of 94 HNSCC outside the oropharynx, six (6%) were HPV16-driven. In these patients, HPV16 E6 seropositivity had lower sensitivity (50%, 95%CI 19-81), but was highly specific (100%, 95%CI 96-100). In conclusion, HPV16 E6 seropositivity appears to be a highly reliable diagnostic marker for HPV16-driven OPSCC with very high sensitivity and specificity, but might be less sensitive for HPV16-driven HNSCC outside the oropharynx.
000120649 536__ $$0G:(DE-HGF)POF3-316$$a316 - Infections and cancer (POF3-316)$$cPOF3-316$$fPOF III$$x0
000120649 588__ $$aDataset connected to CrossRef, PubMed,
000120649 7001_ $$aWichmann, Gunnar$$b1
000120649 7001_ $$0P:(DE-HGF)0$$aBaboci, Lorena$$b2
000120649 7001_ $$0P:(DE-He78)8c4d3a946a1fcde2ded7e17651fd0ed7$$aMichel, Angelika$$b3
000120649 7001_ $$0P:(DE-He78)3b05a05c74fcfafec06747c40ac929c0$$aHöfler, Daniela$$b4
000120649 7001_ $$0P:(DE-He78)1042737c83ba70ec508bdd99f0096864$$aWiesenfarth, Manuel$$b5
000120649 7001_ $$0P:(DE-He78)b12aaacaa142dabed85c6d84d00bf0fb$$aSchroeder, Lea$$b6
000120649 7001_ $$aBoscolo-Rizzo, Paolo$$b7
000120649 7001_ $$0P:(DE-He78)c146c0b611b8fb654444ec078766f5ea$$aHerold-Mende, Christel$$b8$$udkfz
000120649 7001_ $$aDyckhoff, Gerhard$$b9
000120649 7001_ $$aBoehm, Andreas$$b10
000120649 7001_ $$aDel Mistro, Annarosa$$b11
000120649 7001_ $$aBosch, Franz X$$b12
000120649 7001_ $$aDietz, Andreas$$b13
000120649 7001_ $$0P:(DE-He78)d99bad949ba3ae93859eedae5ac266da$$aPawlita, Michael$$b14
000120649 7001_ $$0P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30$$aWaterboer, Tim$$b15$$eLast author
000120649 773__ $$0PERI:(DE-600)1474822-8$$a10.1002/ijc.30697$$gVol. 140, no. 12, p. 2748 - 2757$$n12$$p2748 - 2757$$tInternational journal of cancer$$v140$$x0020-7136$$y2017
000120649 909CO $$ooai:inrepo02.dkfz.de:120649$$pVDB
000120649 9101_ $$0I:(DE-588b)2036810-0$$60000-0002-5010-5236$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000120649 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000120649 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)8c4d3a946a1fcde2ded7e17651fd0ed7$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000120649 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3b05a05c74fcfafec06747c40ac929c0$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000120649 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)1042737c83ba70ec508bdd99f0096864$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000120649 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b12aaacaa142dabed85c6d84d00bf0fb$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000120649 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)c146c0b611b8fb654444ec078766f5ea$$aDeutsches Krebsforschungszentrum$$b8$$kDKFZ
000120649 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)d99bad949ba3ae93859eedae5ac266da$$aDeutsches Krebsforschungszentrum$$b14$$kDKFZ
000120649 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30$$aDeutsches Krebsforschungszentrum$$b15$$kDKFZ
000120649 9131_ $$0G:(DE-HGF)POF3-316$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vInfections and cancer$$x0
000120649 9141_ $$y2017
000120649 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000120649 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000120649 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000120649 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000120649 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bINT J CANCER : 2015
000120649 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000120649 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000120649 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000120649 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000120649 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000120649 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000120649 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bINT J CANCER : 2015
000120649 9201_ $$0I:(DE-He78)F020-20160331$$kF020$$lInfektionen und Krebs-Epidemiologie$$x0
000120649 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lC060 Biostatistik$$x1
000120649 980__ $$ajournal
000120649 980__ $$aVDB
000120649 980__ $$aI:(DE-He78)F020-20160331
000120649 980__ $$aI:(DE-He78)C060-20160331
000120649 980__ $$aUNRESTRICTED